Gene Solutions Expands into Türkiye with AI-Powered Cancer Detection

March 04, 2026
Gene Solutions has announced its entry into Türkiye at the 2nd International Hereditary Cancers Congress, showcasing real-world evidence and ctDNA-powered oncology solutions developed with ATC Genomics.

Gene Solutions has announced its strategic entry into the Turkish market at the 2nd International Hereditary Cancers Congress (IHCC), held February 5–8, 2026, in Antalya, announced in a press release. The event gathered over 600 oncology and genetics experts to discuss evidence-based hereditary cancer care.

In partnership with ATC Genomics, the company presented one of Asia’s largest real-world datasets for AI-powered multi-cancer early detection. It also showcased its clinically validated ctDNA-based oncology portfolio designed for high-risk and hereditary populations.

Gene Solutions stated that the initiative aims to support localized and scalable implementation of genomic medicine in Türkiye, with a focus on improving outcomes for patients with hereditary and high-risk cancers.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

03/04
Ease Health Raises $41 Million to Build AI-Native Platform for Behavioral Health
03/04
Delphyr Raises €1.75 Million to Expand AI Tools for Healthcare Professionals
03/04
DarcyIQ Integrates with Epic and athenahealth EHR Systems
03/04
Guideway Care Acquires Waypoint Healthcare Solutions to Expand AI-Driven Patient Activation
03/04
Perimeter Medical Imaging AI Gains FDA Approval for AI Breast Surgery Device

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You May Also Like